Search results
7 lip 2021 · This guideline is based on evidence up to 2019 regarding the treatment of liver cirrhosis and supports clinical practice by presenting the contents of medical treatment that can be recommended and proposed.
- PMC Free Article
Introduction: sarcopenia 2018. In 2010, the European Working...
- Carvedilol Versus Traditional, Non‐Selective Beta‐Blockers for Adults With Cirrhosis and Gastroesophageal Varices
Overall, carvedilol appears to be as efficacious and safe as...
- Results of Portosystemic Shunt Embolization in Selected Patients With Cirrhosis and Recurrent Hepatic Encephalopathy
Some of the patients with early-stage cirrhosis experience...
- Antacids for Preventing Oesophagogastric Variceal Bleeding and Rebleeding in Cirrhotic Patients
Antacids are often used for emergency treatment of bleeding...
- 410K
The definition of the metabolic syndrome (MetS) was based on...
- PubMed
EASL Clinical Practice Guidelines for the management of...
- PMC Free Article
AASLD develops evidence-based practice guidelines, practice guidances, and patient guidances to share recommended approaches to the diagnostic, therapeutic, and preventive aspects of care.
The following Clinical Practice Guidelines (CPGs) represent the first CPGs on the management of decompensated cirrhosis.
25 sie 2016 · This guide to the practical treatment of patients with cirrhosis summarizes recent developments. It includes advice on medical management, invasive procedures, nutrition, prevention, and...
In addition to the updated antiviral therapy for hepatitis B and C liver cirrhosis, the latest treatments for non-viral cirrhosis, such as alcoholic steatohepatitis/non-alcoholic steatohepatitis (ASH/NASH) and autoimmune-related cirrhosis, are also described.
9 maj 2023 · Outcomes for patients with cirrhosis can be improved with evidence-based therapies directed toward both the etiology of cirrhosis 6-12 and its complications. 13-21 Recent innovations include noninvasive risk stratification of cirrhosis 22,23 as well as interventions that improve survival by preventing or reducing the complications of cirrhosis ...
This guideline is based on evidence up to 2019 regard-ing the treatment of liver cirrhosis and supports clinical practice by presenting the contents of medical treatment that can be recommended and proposed. The disease states of patients with cirrhosis are extremely diverse, and some medical treatment methods are outside the scope of insur-